Carfilzomib associated thrombotic microangiopathy initially treated with therapeutic plasma exchange. Issue 5 (21st November 2014)

• Record Type: Journal Article
• Authors: Sullivan, Matthew R.; Danilov, Alexey V.; Lansigan, Frederick; Dunbar, Nancy M.
• Is Part Of: Journal of clinical apheresis. Volume 30:Issue 5(2016:Oct.)
• Page Start: 308
• Page End: 310
• Publication Date: 2014-11-21
• Subjects: Hemapheresis -- Periodicals; Blood -- Transfusion -- Periodicals; Blood -- Transfusion, Autologous -- Periodicals; Cell separation -- Periodicals; Leukapheresis -- Periodicals; Plasmapheresis -- Periodicals; 615.39
• DOI: 10.1002/jca.21371
• Languages: English
• ISSNs: 0733-2459

Abstract

<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Drug associated thrombotic microangiopathy (TMA) is a rare event causing thrombocytopenia, microangiopathic anemia, renal failure, and neurologic abnormalities. Here, we present a case of TMA that occurred during the first cycle of treatment with carfilzomib for relapsed multiple myeloma. J. Clin. Apheresis, 2014. © 2014 Wiley Periodicals, Inc.</p> </abstract>